To assess whether the BM failure that developed in Casp8−/− mice was due to the propensity of Casp8−/− HSPCs to suffer infections or inflammation-induced cell death, we compared the responses of Casp8−/− and WT HSPCs to low-dose TLR agonists or inflammatory cytokines. This evidence concerns the gene CASP8 and infection.